Policies on essential drugs help contain costs

Rich countries seeking to contain escalating drug expenditures should learn from the experience of the many developing countries that have adopted WHO's essential medicines policies, says Hogerzeil (p 1169). Although rich countries have adopted components of the policies WHO advocates, including evidence based clinical guidelines, they should also consider establishing lists of essential medicines based on sound scientific review and public health imperatives.